Additional investigations include serum studies to identify antibodies specific to MS mimics, such as anti-aquaporin-4 antibodies for neuromyelitis optica spectrum disorder (NMOSD) and an antinuclear antibody (ANA) panel for rheumatologic conditions [62],[63]. This evidence concerns the gene BTG3 and neuromyelitis optica.